<DOC>
	<DOCNO>NCT01028378</DOCNO>
	<brief_summary>This purpose study evaluate safety effectiveness topography-based custom ablation treatment use ALLEGRETTO WAVEÂ® Eye-Q 400 Hz laser system treat myopia hyperopia .</brief_summary>
	<brief_title>Safety Efficacy Study Topography-Guided LASIK Treat Myopia Hyperopia</brief_title>
	<detailed_description />
	<mesh_term>Myopia</mesh_term>
	<mesh_term>Hyperopia</mesh_term>
	<criteria>18 year age old ; Signed Informed Consent ; Willingness ability comply schedule followup visit ; candidate topography guide LASIK treatment myopia hyperopia eye base doctor examination eye ; Intended treatment target emmetropia ; Stable refraction ( 0.5 D less change manifest refraction spherical equivalent ( MRSE ) per year ) 12 month longer , base previous clinical record prescription history ( e.g. , old glasses/contact lens prescription ) . Able obtain reliable corneal topography use determine TCAT treatment plan ; Best spectaclecorrected visual acuity ( BSCVA ) 20/25 good eye ; Less 0.75 D spherical equivalent ( SE ) difference cycloplegic manifest refraction . Is contact lens wearer , wear contact lens , discontinue wear contact lens require period time complete contact lens stability check ; able maintain eye position steady course treatment . History prior refractive treatment ; Mixed astigmatism refractive error ; Lenticular astigmatism , investigator 's opinion , clinically significant ; Corneal topography show evidence keratoconus , keratoconus suspect , forme fruste keratoconus , pellucid marginal degeneration , topographic abnormality would place eye risk develop postrefractive corneal ectasia ; Treatment plan TCAT would predict residual stromal bed thickness less 250 micron ; History current evidence corneal anterior segment disease might reasonably expect affect outcome treatment ( e.g. , herpes simplex keratitis , herpes zoster keratitis , recurrent erosion syndrome , corneal melt , corneal dystrophy , etc . ) ; Evidence retinal vascular disease ; Female patient pregnant lactating plan become pregnant course study ; A know sensitivity study medication ; Nystagmus condition would prevent steady gaze LASIK treatment diagnostic test ; Corneal dystrophy corneal guttae ; Pathology involve iris ( e.g. , coloboma , tear , cut , significant pigment loss , etc . ) ; Residual , recurrent active ocular pathology ; Previous intraocular corneal surgery might confound outcome increase risk study ; Acute chronic illness might increase risk confound outcome study ( e.g. , diagnose autoimmune disease , systemic connective tissue disease , clinically significant atopic disease , diabetes mellitus , etc . ) The use systemic medication may confound outcome increase risk study , include , limited : corticosteroid antimetabolites ; Intraocular pressure &gt; 23 mm Hg , history glaucoma , glaucoma suspect ; An increase risk develop strabismus treatment ( applicable treatment hyperopic refractive error ) ; Presence history condition finding , investigator 's opinion , make patient unsuitable candidate LASIK study participation may confound outcome study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>